Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


GREY MICHAEL G Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns: Disposed/sold 39,361 shares @ $116.5, valued at $4.6M
Disposed/sold 48,031 shares @ $116.5, valued at $5.6M
Disposed/sold 10,000 shares @ $116.5, valued at $1.2M
Disposed/sold 8,548 options to buy @ $28.53, valued at $243.9k
Disposed/sold 23,092 options to buy @ $15.23, valued at $351.7k
Disposed/sold 31,153 options to buy @ $15.12, valued at $471k
Disposed/sold 32,161 options to buy @ $13.87, valued at $446.1k
Disposed/sold 4,016 restricted stock units @ $0
09/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/27/2023 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns: Gifted 50,000 shares @ $0
06/09/2023 4 GREY MICHAEL G (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 14,608 shares @ $29, valued at $423.6k
Exercised 14,608 options to buy @ $2.936, valued at $42.9k
06/08/2023 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns: Granted 17,500 options to buy @ $9.01, valued at $157.7k
06/08/2023 144 Form 144 - Report of proposed sale of securities:
05/26/2023 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns: Granted 30,000 options to buy @ $2.26, valued at $67.8k
05/04/2023 4 GREY MICHAEL G (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 14,608 shares @ $28, valued at $409k
Exercised 14,608 options to buy @ $2.936, valued at $42.9k
05/03/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 4 GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns: Exercised 3,913 restricted stock units @ $0
09/02/2022 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns: Exercised 50,000 options to buy @ $1.97, valued at $98.5k
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns: Granted 17,500 options to buy @ $2.09, valued at $36.6k
05/27/2022 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns: Granted 22,500 options to buy @ $1.32, valued at $29.7k
05/02/2022 4 GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns: Exercised 4,223 shares @ $0
Paid exercise price by delivering 1,139 shares @ $98.56, valued at $112.3k
Granted 3,913 restricted stock units @ $0
Exercised 4,223 restricted stock units @ $0
12/20/2021 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns: Granted 50,000 options to buy @ $2.48, valued at $124k
07/23/2021 4 GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns: Sold 1,000 shares @ $100, valued at $100k
Sold 4,000 shares @ $100.05, valued at $400.2k
Exercised 5,000 options to buy @ $2.37, valued at $11.9k
06/08/2021 4 GREY MICHAEL G (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $16.88, valued at $287k
05/21/2021 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns: Granted 10,000 options to buy @ $15.24, valued at $152.4k
04/30/2021 4 GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns: Exercised 11,098 shares @ $0
Paid exercise price by delivering 2,993 shares @ $94.62, valued at $283.2k
Granted 4,223 restricted stock units @ $0
Exercised 11,098 restricted stock units @ $0
04/15/2021 3/A GREY MICHAEL G (Executive Chairman) has filed a Form 3/A on Reneo Pharmaceuticals, Inc.
04/15/2021 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns: Converted 20,162 shares @ $0
Converted 90,222 preferred shares @ $0
04/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/12/2021 4 GREY MICHAEL G (Executive Chairman) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns: Granted 14,000 options to buy @ $15, valued at $210k
04/08/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 GREY MICHAEL G (Director) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 1,475 shares @ $0
Granted 2,155 options to buy @ $214.47, valued at $462.2k
12/16/2020 4 GREY MICHAEL G (Director) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 379 shares @ $241.22, valued at $91.4k
Sold 857 shares @ $242.2882, valued at $207.6k
Sold 1,815 shares @ $243.345, valued at $441.7k
Sold 1,653 shares @ $244.4544, valued at $404.1k
Sold 1,284 shares @ $245.1129, valued at $314.7k
Sold 1,807 shares @ $246.7258, valued at $445.8k
Sold 1,997 shares @ $247.6224, valued at $494.5k
Sold 1,019 shares @ $248.5464, valued at $253.3k
Sold 89 shares @ $249.42, valued at $22.2k
Exercised 10,900 options to buy @ $16.84, valued at $183.6k
10/08/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/07/2020 4 GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns: Sold 1,755 shares @ $73.35, valued at $128.7k
Exercised 1,755 options to buy @ $3.95, valued at $6.9k
08/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2020 4 GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns: Sold 1,755 shares @ $60, valued at $105.3k
Exercised 1,755 options to buy @ $3.95, valued at $6.9k
06/26/2020 4 GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns: Sold 1,755 shares @ $55, valued at $96.5k
Exercised 1,755 options to buy @ $3.95, valued at $6.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy